Cardioneuroablation for Reflex Syncope and Exercise Capacity

Recruiting N/A Interventional Study
Syncope, Vasovagal
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
100 (estimated)
Sponsor
Centre of Postgraduate Medical Education · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Cardioneuroablation (CNA) is a new promising method to treat reflex syncope which is due to vagally-induced functional sinus arrest or atrio-ventricular block (AVB). Although the procedure is effective in \> 80% of patients, there are potential adverse effects associated with the lack of vagal protection. One of them is increased sinus rate and possible worsening of exercise capacity. However, it …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * severe, recurrent symptoms due to reflex syncope or recurrent presyncope due to slow heart rate * ECG documented asystole \>3 seconds * ineffective prior non-pharmacological treatment * positive baseline atropine test (sinus rate acceleration \> 30% and no atrio-ventricular bl…
Contacts

Piotr Kulakowski, PhD

604455081

kulak@kkcmkp.pl

CONTACT

Anieszka Sikorska, PhD

604106455

sikorska.agnieszka.anna@gmail.com

CONTACT